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Introduction
To infect cells, HIV-1 virions need to fuse their membrane with
the target cell membrane, a process triggered by the viral envelope
(env) glycoprotein trimer [1,2]. Due to its key function in the virus
life cycle and as prime target for neutralizing antibodies and entry
inhibitors, analyses of env trimer structure and function remain in
the focus of current HIV vaccine and drug research [3–5]. Each
env trimer consists of three heterodimeric protomers, composed of
the non-covalently associated gp120 surface and gp41 transmem-
brane subunits. Binding of gp120 to the primary receptor CD4 on
target cells triggers conformational changes in gp120 that expose
the binding site of a co-receptor, most commonly CCR5 or
CXCR4 [6]. Subsequent co-receptor binding activates the gp41
transmembrane subunits, which triggers a prototypic class I fusion
process via insertion of the N-terminal fusion peptides into the
target cell membrane. Refolding of the gp41 N- and C-terminal
heptad repeat regions into six-helix bundles drives approximation
and fusion of viral and target cell membranes [1,7,8].
While the HIV entry process has been defined in considerable
detail, we currently lack information on the stoichiometric
relations of interacting molecules. Likewise, the thermodynamic
requirements of membrane fusion pore formation and pore
enlargement, enabling passage of the viral core into the target
cell cytoplasm, are only partially understood [9–11]. The energy
required for the entry process is generated by structural
rearrangements of the envelope trimer that follow receptor
binding [7,8,12]. How many trimers must engage in receptor
interactions (a number referred to as stoichiometry of entry) [13–
15] in order to elicit the required energy to complete fusion has
not been conclusively resolved. Whether HIV needs one or more
trimers to complete entry will strongly influence virion infectivity
and efficacy of neutralizing antibodies targeting the trimer.
Previous studies resulted in contradicting stoichiometry estimates,
suggesting that either a single trimer is sufficient for entry [13] or
that between 5 to 8 trimers are required [14,15]. In comparison,
for Influenza A virus, which achieves membrane fusion through
the class I fusion protein hemagglutinin (HA), postulated necessary
HA trimer numbers range from 3 to 4 [16–18] to 8 to 9 [13].
Calculations based on the energy required for membrane fusion
suggested that indeed the refolding of a single HIV envelope
trimer could be sufficient to drive entry [7,8]. Numerous lines of
evidence however suggest that several env-receptor pairings are
commonly involved in the HIV entry process. Electron micros-
copy analysis of HIV entry revealed the formation of an ‘‘entry
claw’’ consisting of several putative env-receptor pairs [19], which
is supported by biochemical analyses indicating that the number of
CCR5 co-receptors needed for virus entry differs among HIV-1
isolates and requires up to 6 co-receptors [20,21].
Precise delineation of the stoichiometry of entry, as we present it
here, substantially contributes to our understanding of HIV
pathogenesis by defining a viral parameter that steers virus entry
capacity, potentially shapes inter- and intra-host transmission by
setting requirements for host cell receptor densities, and by
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defining stoichiometric requirements for virion neutralization. The
latter is of particular importance considering the ongoing efforts to
generate neutralizing antibody based therapeutics and vaccines
targeting the HIV-1 entry process [3,4,22].
Results
The number of envelope trimers required for entry differs
among HIV-1 isolates
To estimate the stoichiometry of entry (in the following referred
to as T) we employed a previously described combination of
experimental and modelling analyses [13–15]. Our strategy
centers on the analysis of env pseudotyped virus stocks carrying
mixed envelope trimers consisting of functional (wt) and dominant-
negative mutant env, where a single dominant-negative env
subunit incorporated into a trimer renders the trimer non-
functional. We included envs of 11 HIV-1 strains in our analysis
covering subtypes A, B and C and a range of env characteristics
such as primary and lab-adapted strains, different co-receptor
usage and different neutralization sensitivities (Table 1).
To derive estimates of T from mixed trimer experiments two
key parameters need to be considered: the mean virion trimer
numbers and the distribution of virion trimer numbers across a
virion population [14,15]. To assess virion trimer numbers, we
determined p24 and gp120 content of purified virus stocks by
ELISA. Although only an approximation, as also partially shed
and non-functional trimers are accounted for, this analysis yielded
upper limits of virion trimer content. We observed between 6 to 20
trimers per virion among the 11 strains probed (Table 1), which is
in close agreement with previous estimates of HIV-1 virion trimer
content [23–28]. While trimer incorporation into pseudotyped
particles may be lower than on replication-competent virus [29],
this does not preclude estimation of T as trimer content is
controlled for in our mathematical analysis. Since available
experimental data do not provide information on the distribution
of trimers across virion populations (i.e. frequencies of virions with
a given trimer number in the population), we utilized previously
determined trimer number variation across virions in our
modeling [26].
Key in our experimental design are dominant-negative env
mutants. To obtain robust estimates of T we performed the
experiments with two individual env mutations that both lead to a
complete loss in entry capacity, either by a mutation of the Furin
cleavage site (R508S/R511S) [13,30,31] or a mutation of the gp41
fusion peptide (V513E) [13,32]. Importantly, expression levels of
the mutant envs were in the range of 80 to 100% of the
corresponding wt envs (Table 1), ascertaining that during mixed
trimer experiments env expression levels on virions follows the
ratio of wt and mutant env plasmids transfected into virus
producer cells.
To assess T, mixed trimer expressing pseudovirus stocks of each
strain were generated by transfecting producer cells with different
ratios of mutant and wt env plasmids ranging from 0 to 100% of
the dominant-negative mutant env. The resulting virus stocks were
probed for infectivity on TZM-bl reporter cells and infectivity was
plotted as function of mutant env content (Fig. 1A and B). Based
on our model [15], differences in T result in different infectivity
plots in this graphical analysis (Fig. 1A). Intriguingly, the 11 envs
showed variable patterns suggesting that the strains differ in T
(Fig. 1B). The mixed trimer infectivity data (Fig. 1B) and the mean
virion trimer numbers (Table 1) were then used to infer T of each
strain by our model. This resulted in estimates of T ranging from 1
to 7 trimers for the 11 HIV strains tested (Fig. 1C, S1 Table and
S1 Fig.), with the majority of strains requiring 2 to 3 trimers for
entry. Of note, the data derived with the V513E and R508S/
R511S mutant returned closely matching results with identical
estimates for T (n= 4) or estimates differing only by 1 (n= 6)
(Fig. 1C). The only higher discrepancy was observed for the highly
neutralization sensitive, T cell line adapted strain NL4-3 where the
two env mutations appeared to have individual effects on the
readout but both yielded estimates of T that were amongst the
highest in the env panel (T= 7 with V513E and T=4 with
R508S/R511S).
To verify that the mathematical approach (in the following
referred to as ‘‘basic model’’) provides a valid estimate of T, we
probed several alternative analyses of the data shown in Fig. 1B.
These analyses incorporate previously described extensions of the
basic model that account for additional parameters that could
potentially influence data acquisition and analysis [15]. The model
extensions showed for the majority of strains a significantly
improved curve fit to the experimental data (S1 Table). However,
these analyses frequently yielded highly divergent values of T and
the additional model parameters included in the model extensions
for the two dominant-negative mutants of the same strain (S1
Table and exemplified for the CAP88 Env in S2 Fig.). This was in
stark contrast to the basic model where the two independent T
estimates of each strain were with few exceptions in close
agreement (Fig. 1C and S1 Fig.). As we can safely assume that
the parameter estimates for the two different mutations of the
same strain should be similar we can reject the model extensions.
A further indication that the model extensions we probed are not
valid in the context of our analysis was that the derived estimates
of T were in many cases implausibly high whereas the basic model
generated estimates that fit the described range of trimer levels on
HIV virions. We are thus confident that the basic model we utilize
for the estimation of T is valid and provides robust estimates.
The mean virion trimer number of the probed virus stocks is an
important model parameter in our analysis of T and fluctuations
in the mean virion trimer number may therefore influence the
estimates. To test the influence of mean virion trimer number
variation on our estimates of T we performed additional data
analyses where instead of the measured individual trimer numbers
(Table 1), identical mean trimer numbers for all 11 strains were
Author Summary
Our estimates of the HIV-1 entry stoichiometry, that is the
number of envelope glycoprotein trimers needed to
mediate fusion of viral and target cell membrane, close
an important gap in our understanding of the HIV entry
process. As we show, stoichiometric requirements for
envelope trimers differ between HIV strains and steer virus
entry efficacy and virus entry kinetics. Thus, the entry
stoichiometry has important implications for HIV transmis-
sion, as demands on trimer numbers will dictate the
infectivity of virus populations, target cell preferences and
virus inactivation by trimer-targeting inhibitors and neu-
tralizing antibodies. Beyond this, our data contribute to
the general understanding of mechanisms and energetic
requirements of protein-mediated membrane fusion, as
HIV entry proved to follow similar stoichiometries as
described for Influenza virus HA and SNARE protein
mediated membrane fusion. In summary, our findings
provide a relevant contribution towards a refined under-
standing of HIV-1 entry and pathogenesis with particular
importance for ongoing efforts to generate neutralizing
antibody based therapeutics and vaccines targeting the
HIV-1 envelope trimer.
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assumed. We chose 3 values for this comparison that covered the
range of trimer numbers measured across our panel: mean trimer
numbers of 5 and 26 (representing the lowest and highest trimer
contents measured in individual experiments) and a mean trimer
number of 13, the mean of trimer numbers measured across our
virus panel. Applying these trimer numbers to our data set we
obtained estimates of T ranging from 1 to 17 trimers (S3A Fig.).
To determine the mean virion trimer numbers of the virus
stocks we measured gp120 and p24 contents. This allows to derive
virion numbers based on previously reported estimates of 1200 to
2500 p24 molecules per virion [23,24,33]. We chose an average
estimate of 2000 p24 molecules per virion to derive the mean
trimer numbers shown in Table 1. To investigate the influence of
p24 assumptions on our analysis we also tested a higher p24
content estimate of 2400 molecules per virion as recently reported
[33], consequently yielding 20% higher mean virion trimer
numbers across all viruses. Employing these 20% higher trimer
numbers in our analysis had only a modest effect on the T
estimates yielding identical or slightly higher (mostly by one trimer)
estimates of T (S3B Fig.). While these analyses confirm that
absolute values of T vary depending on the mean virion trimer
number assumed for the analysis, the differences in T among the
11 strains persisted, highlighting that they reflect qualitative entry
properties of the respective envs. Hence, independent of the
absolute mean trimer numbers, differences in T between viral
strains can be detected by our approach.
As a further assay verification we tested the influence of target
cells on our estimation of T. We reasoned that if our experimental
approach truly measures the stoichiometry of entry, then the
obtained data should be a sole function of the envelope trimer and
not be influenced by target cell type and receptor density. We thus
chose TZM-bl cells as target cells for their known reproducible
performance and good signal to noise ratio in the luciferase
reporter readout. Since these engineered cells overexpress the
entry receptors of HIV and thus do not reflect features of
physiological relevant target cells, we sought to verify that the
obtained T estimates are indeed independent of the target cells
used. To this end we chose two envelopes which yielded a low T
estimate (primary isolate JR-FL, T=2) and a high T estimate
(lab-adapted strain SF162, T=4 to 5) on TZM-bl cells and
repeated the estimation of T on PBMC as target cells (Fig. 1D and
E and S4 Fig.). As anticipated, we obtained for both viruses almost
identical curves and T estimates as with the TZM-bl reporter cells,
confirming that estimates of T are truly independent of the target
cell type. Hence, use of TZM-bl cells for our assay setup is
appropriate and the estimated T values are valid for physiolog-
ically relevant target cells of HIV-1.
Increased virus entry fitness is reflected by low entry
stoichiometry
The entry stoichiometry of a strain can be expected to influence
virus population infectivity as strains with a low T will benefit from
a higher proportion of the virus population carrying the required
minimum trimer number (Fig. 2A). To directly probe the
influence of T on virus infectivity we assessed the in vitro
infectivity of the 11 HIV-1 strains in our panel. Of note, in the
context of pseudoviruses infectivity is solely determined by the Env
genes. Intriguingly, infectivity proved to be inversely correlated
with T (r =20.635, p = 0.036; Fig. 2B) indicating that strains that
accomplish entry with low T are more infectious than strains with
high T. Of note, we observed very divergent infectivities also for
strains with very similar estimates of T (Fig. 2B). This is likely
caused by different mean trimer numbers of the strains, as the
mean trimer number in conjunction with T dictates virion
population infectivity (Fig. 2A, C and D). For instance, amongst
the viruses with T=2 strain P3N has the highest infectivity and
highest mean virion trimer number (20.3) whereas ZM214, the
strain with lowest infectivity also has the lowest mean virion trimer
number (6.7) measured across these viruses (Table 1). It can
expected that additional factors beyond T and trimer numbers,
such as propensity to shed gp120 or differential affinity for CD4,
which are not covered by our analysis, may further contribute to
different infectivity of the strains.
To investigate the interplay between entry stoichiometry and
infectiousness of a virus population in more detail, we performed
mathematical analyses of the relation between entry stoichiometry
and trimer numbers per virion of a virus population. We found
Table 1. HIV-1 strains and mutants.
Strain Subtype Trimer Numbersa
R508S/R511S expression
levelb V513E expression levelb
SF162 B 16.0 95 90
NL4-3 B 13.5 85 90
JR-FL B 11.8 85 95
RHPA B 13.8 90 95
REJO B 10.5 100 100
AC10 B 15.0 100 100
P3N B 20.3 100 100
ZA110 B 15.0 80 100
CAP88 C 7.3 100 100
ZM214 C 6.7 100 100
BG505 A 9.5 95 100
Eleven HIV-1 strains from subtypes A, B and C were employed in this study. Mean virion trimer numbers and expression levels of the dominant-negative R508S/R511S
and V513E mutants of the utilized virus preparations are shown.
aMean virion trimer numbers as estimated by gp120/p24 ELISA of purified HIV-1 pseudoparticle stocks. Data are means of 2 to 3 independent experiments.
bThe expression level of the dominant-negative mutants is recorded as percentage of the corresponding wt env based on gp120 quantification by ELISA of purified HIV-
1 pseudoparticle stocks.
doi:10.1371/journal.ppat.1004595.t001
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that indeed the entry stoichiometry steers virus population
infectivity, with a higher entry stoichiometry resulting in a lower
fraction of potentially infectious virions (Fig. 2C and D). Hence,
the T of a strain and the therewith linked entry capacity may
potentially contribute to the infectious to non-infectious particle
ratio which is known to be low for HIV-1 [24].
Perturbation of trimer integrity induces changes in entry
stoichiometry
To further explore the relation between virus infectivity and T
we analyzed envs with deletions of the gp120 variable loops 1 and
2 (V1V2) and compared them to the matching wildtype envs. As
we and others have previously shown, V1V2 deletion causes a
dramatic reduction of virus infectivity through impairment of
trimer integrity (Fig. 3A and [34–38]). When we probed T and
compared the infectivity curves of the wt and V1V2-deleted env
pairs, we observed distinct curve shifts of the V1V2-deleted envs
across the majority of strains (Fig. 3B and C). Indeed, T of the
V1V2-deleted envs proved significantly increased compared to the
matching wt envs (Fig. 3D; mean T of 3.1 for wt envs versus mean
T of 6.85 for V1V2-deleted envs; paired t test p = 0.0069).
Importantly, this reduction in entry efficiency and the ensuing
high estimates for T upon V1V2 deletion are not simply caused by
reductions in env content of these virions, as V1V2-deleted env is
expressed to similar levels on virions as the corresponding wt env
(80–100% of wt, S5 Fig.). While expression levels of trimers
certainly influence the estimates of T, we verified that the observed
env content reduction of V1V2 deleted viruses was too low to
inflict an overestimation of T (S5 Fig.) highlighting that indeed
functional properties and not quantity of the respective wt and
DV1V2 envelopes are decisive in defining T.
To further investigate the interplay between trimer numbers
and T we produced pseudoviruses which expressed JR-FL wt and
JR-FL DV1V2 with a deletion of the gp41 cytoplasmic tail (CT) as
this is known to lead to an increased incorporation of trimers into
virions [39,40]. Indeed, CT deletion resulted in approximately 2-
fold increased levels of trimers on virions (S6A–S6B Fig.). In
support of the strong interplay between virion trimer numbers and
Fig. 1. HIV-1 strains differ in the number of trimers required for entry. (A) Theoretical predictions of relative virus infectivity over the fraction
of dominant-negative mutant env (fm) according to our model. Curves for T ranging from 1 to 8 are shown assuming the trimer number distribution
across virions to follow a discretized Beta distribution with constant mean 12.95 and variance 45 [15]. (B) Relative infectivity of mixed trimer infection
experiments with 11 HIV-1 strains using the R508S/R511S (left) and V513E (right) dominant-negative env mutants. Infectivity of pseudotyped virus
stocks expressing the indicated ratios of wild type and dominant-negative mutant envs was measured on TZM-bl reporter cells. Infectivity of virus
stocks containing solely wt envelope were set as 100%. Data depict mean and SD from 2 to 4 independent experiments. For each virus the individual
curve fits resulting from the model to the obtained data were evaluated (S1 Fig.). (C) Mathematical estimates of T derived from the data shown in (B).
The R508S/R511S (black circles) and V513E (open squares) mutations were analyzed individually. Bootstrap analyses demonstrating the robustness of
the obtained estimates of T are shown in S1 Fig. (D and E) Mixed trimer virus stocks for strain JR-FL (D) and SF-162 (E) carrying the V513E mutation
were assayed on healthy donor PBMC and compared to data obtained with TZM-bl target cells. Data depict mean and SD from 2 independent
experiments.
doi:10.1371/journal.ppat.1004595.g001
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Fig. 2. The entry stoichiometry governs virus population infectivity. (A) Scheme depicting the influence of the entry stoichiometry on virus
population infectivity. Different Ts (exemplified here: T = 1 and T = 7) will determine the minimum number of trimers that a virion requires in order to
be infectious. (B) Correlation analysis (Pearson) of virus strain infectivity (measured by infection of TZM-bl reporter cells and expressed in arbitrary
relative light units (RLU) per ml of virus stock) and the estimated T (plotted as mean of the independent R508S/R511S and V513E estimates shown in
Fig. 1C). Virus infectivities are depicted as mean values derived from 3 independent experiments. (C) Mathematical modeling to investigate the
influence of entry stoichiometry on virion population infectivity. The data depict how T= 2 and T= 7 translate into different fractions of a virion
population being potentially infectious, in dependence on the trimer number distribution across the virion population. As shown in (D), the overall
infectivity of a virus population decreases with increasing T. For (C) and (D) we assumed the trimer number distribution across virions to follow a
discretized Beta distribution with constant mean 12.95 and variance 45 [15].
doi:10.1371/journal.ppat.1004595.g002
Fig. 3. V1V2 deletion impairs virus infectivity and is reflected by a high stoichiometry of entry. (A) Comparison of infectivity of
pseudoviruses expressing wt and V1V2-deleted envs upon infection of TZM-bl cells. Data points depict mean values of luciferase reporter activity per
ml virus stock measured in 3 independent experiments. The p-value was calculated by a paired t-test. (B and C) Relative infectivity of mixed trimer
infection experiments of 10 wt envs and their V1V2 deleted variants using the R508S/R511S (B) and the V513E (C) dominant-negative mutations are
shown. Infectivity of pseudotyped virus stocks expressing the indicated ratios of dominant-negative mutant envs was measured on TZM-bl cells.
Infectivity of virus stocks containing solely functional envelope were set as 100%. Data depict mean and SD from 2 to 4 independent experiments. (D)
Estimates of T for the wt and V1V2-deleted envs derived from mixed trimer experiments. Data points are the mean of the individual estimates of T
obtained with the R508S/R511S and V513E dominant-negative mutations. The p-value was calculated by a paired t-test.
doi:10.1371/journal.ppat.1004595.g003
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infectivity thresholds defined by T, the infectivity of both viruses
upon CT deletion was increased (S6C Fig.). Intriguingly, the
increase in infectivity upon CT deletion was higher for JR-FL
DV1V2 (9-fold) compared to JR-FL wt (2-fold), highlighting that
envelopes with a reduced entry capacity, as here JR-FL DV1V2,
benefit more if virions carry higher trimer numbers and thus meet
the stoichiometric requirements for entry (S6D–S6E Fig.).
Virus entry kinetics reflect requirements for trimer
numbers during entry
The number of trimers required for HIV entry likely influences
virus infectivity in many ways. Besides determining a threshold
trimer content that renders virions infectious, different T’s could
also manifest in different kinetics of the entry process as viruses
with higher T may require more time to recruit and engage the
necessary number of trimer-receptor pairings. To determine virus
entry kinetics we employed a time-of-inhibitor addition experi-
ment to derive the time required per virus strain to reach 50% of
entry into target cells (Fig. 4A and S7A–S7B Fig.). Synchronized
infection following spinoculation and temperature arrest in this
assay setup allows assessment of entry kinetics solely as factor of
envelope function post attachment to the target cells. When
comparing the entry kinetics of the wt and V1V2-deleted strains
we found that V1V2-deleted envs showed significantly delayed
entry into target cells (Fig. 4B; mean times to 50% entry
19.9 minutes for wt envs and 37.7 minutes for V1V2-deleted
envs; paired t-test p= 0.0002). As stated above, a potential
explanation for this is that more time is required for V1V2-
deleted strains to assemble a sufficient number of trimers in the
virus-target cell contact zone to achieve entry. Indeed, we found a
strong correlation between the estimated T and half-maximal
entry time when all viruses, wt and V1V2-deleted strains, were
analyzed (Fig. 4C; r = 0.568, p = 0.0073) but also for wt envs alone
(r = 0.649, p= 0.0307), highlighting that entry stoichiometry and
entry kinetics are tightly linked. The fact that we observe a
significant correlation between estimated T and half-maximal
entry time does however not exclude that additional processes
beyond the recruitment of the necessary number of trimer-
receptor pairings also influence the entry kinetics. Rates of CD4
and co-receptor binding and speed of the ensuing conformational
rearrangements may differ between strains [41] and thereby
contribute to the overall variance in entry kinetics. Additionally,
for virions with a high T it must be considered that formation of
the required number of contacts with the target cell may need
longer time periods during which virions may detach again or
decay before entry is completed [42].
Naturally occurring loss of the N160 glycosylation site
influences the stoichiometry of entry
To further explore the relationship between the entry stoichi-
ometry and infectivity we performed additional studies with the
subtype C strain CAP88 [43], which had the highest T and lowest
infectivity within our panel (Fig. 1B, 1C and 2B). CAP88 is a
transmitted/founder virus which carries a lysine (K) at position
160 of gp120, a site frequently targeted by neutralizing antibodies
[44]. Among 4894 Env sequences deposited in the Los Alamos
HIV Sequence Database asparagine (N) at position 160, as part of
an N-linked glycosylation sequon, is with 93.3% the most
prevalent residue at position 160 [45]. Loss of this glycosylation
site is both associated with escape from PG9/PG16-like antibodies
and decreased entry capacity [38,46–48]. Supporting this we
found that reconstitution of the N-linked glycosylation site
(K160N) in CAP88 results in a 4-fold increase in virus infectivity
(Fig. 5A and [38]) highlighting the importance of N160 for env
functionality. To probe if the increased infectivity of the CAP88
K160N mutant may be due to changes in trimer structure and
function that result in a reduction of T, we analyzed T of CAP88
wt and CAP88 K160N (S8A–S8B Fig.). Indeed, we found that the
increased infectivity of CAP88 K160N is reflected by a decreased
T (Fig. 5B and S8C Fig.). As this example highlights, changes in
trimer structure inferred by naturally occurring mutations,
possibly due to antibody escape, can result in a decreased entry
capacity of the respective env, which in turn is reflected by an
increase in the stoichiometry of entry.
Entry inhibitor escape mutations can increase the
stoichiometry of entry
The finding that a single point mutation in the CAP88 env
could dramatically alter entry fitness and entry stoichiometry
prompted us to further explore the influence of point mutations on
env entry phenotype. To this end we selected three JR-FL variants
mimicking resistance mutants as they may occur in vivo during
neutralization escape: the JR-FL D664N escape mutant resistant
to the MPER antibody 2F5, the JR-FL V549M N554D mutant
which has a highly increased resistance against the entry inhibitor
T-20 [49], and a JR-FL env with point mutations N332S P369L
M373R and D664N rendering it resistant against the broadly
neutralizing antibodies (bnAbs) PGT128, 2G12, b12 and 2F5 (S9
Fig.). While all three JR-FL variants showed similar mean virion
trimer numbers as JR-FL wt, we observed differences in env
infectivity with the 2F5 escape mutant infecting equally well as JR-
FL wt whereas the T-20 and the multiple bnAb escape mutant env
showed strongly reduced infectivity at 9% and 19% of JR-FL wt,
respectively (Fig. 6A). When we compared the three escape
mutant envs and JR-FL wt in the mixed trimer assays we observed
a distinct curve shift for both dominant negative mutants of the T-
20 escape variant (Fig. 6B), while the other three envs gave almost
identical curves. Mathematical analysis of the data indeed revealed
that the T-20 escape mutant requires 4 to 6 trimers for entry while
all other mutants, like JR-FL wt, require 2 trimers (Fig. 6C).
Hence, the T-20 escape mutant showed both, an increase in T and
a loss in infectivity while the bnAb escape mutant env maintained
T despite showing infectivity loss, confirming our earlier findings
that viruses with the same T can still show a wide variation of
infectivities (Fig. 2B). This can possibly be attributed to increased
trimer decay rates or variations in CD4 and co-receptor
engagement, especially since the bnAb escape mutant carried
mutations in the CD4 binding site. Interestingly, the increased
demand of the T-20 escape mutant for trimers during entry was
also reflected in delayed entry kinetics of this env variant (Fig. 6D)
[50]. These entry characteristics of the T-20 escape mutant are
intriguing as the resistance mutations lie in the heptad repeat
region of gp41 and interfere with six-helix bundle formation,
which is a key step providing energy for membrane fusion during
the entry process [51]. Thus, it is mechanistically plausible that the
mutant env may require more trimers for entry to compensate for
the disturbed six-helix bundle formation and generate sufficient
energy to achieve membrane fusion.
Discussion
Fusion of biological membranes, as required for entry of
enveloped viruses, occurs in a plethora of cellular processes. In the
case of HIV, fusion is executed by envelope glycoprotein trimers
upon interaction with adequate receptor molecules on the target
cell membrane [1,8]. While the principle steps are known and
thought to be shared across different biological systems and
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membrane types [7,52,53], the exact mechanisms and stoichio-
metric and thermodynamic requirements of most membrane
fusion processes are not completely resolved [1,8,10,11,54,55].
Definition of the components involved in HIV entry and the
membrane fusion process is of particular interest as improved
understanding of the determinants of HIV entry bears the promise
to funnel the development of enhanced strategies to prevent and
treat viral infections [1,7]. The efficacy of HIV entry shapes inter-
and intra-host transmission and determines the vulnerability to a
range of therapeutic and preventive strategies such as neutralizing
antibodies, entry inhibitors and antibody based vaccines. Consid-
ering that the stoichiometry of entry defines the number of trimers
required for a virus to infect, in turn it also defines the number of
trimers on a virion that need to be blocked by neutralizing
antibodies. Depending on the stoichiometry of entry the quantities
of antibody needed for effective neutralization can therefore vary
substantially [56] (S10 Fig.).
To resolve molecular requirements of HIV membrane fusion,
we explored in the present study the stoichiometry of HIV-1 entry
(T), which defines the number of envelope trimers required per
virion to fuse with the target cell membrane and thereby initiate
infection [13–15]. Our estimates of T are based on a combined
strategy of experimental data acquisition and mathematical
modelling. We analyzed envelopes from 11 HIV-1 strains
including different HIV subtypes, CCR5 and CXCR4 users,
and envelopes with open (lab adapted strains) and closed (primary
isolates) trimer conformation. We found that T differs substantially
between individual strains with measurements ranging from 1 to 7
trimers that are required for entry. While a previous study
suggested that HIV 21 isolates generally require only a single
trimer for entry [13] our analysis retrieved values for T which
were, with one exception (strain REJO), greater than 1, supporting
the findings of alternate modelling approaches by us and others
[14,15]. Of note, only one of the two dominant-negative env
mutants we probed recorded T=1 for the strain REJO while the
other mutant yielded an estimate of T=2. Thus, while our data
cannot exclude that T= 1 for some strains, based on our
observations a range of different entry stoichiometries as we
describe here seems more plausible.
We postulate two potential underlying causes for the variations
in T we observe across strains. Our estimates are based on virion
trimer content measurements by ELISA and are therefore a
composite of functional and non-functional trimers present on
virions. Considering this, a high estimate of T may be derived as
the consequence of premature trimer inactivation through rapid
trimer decay [38,57], or a spontaneous adoption of the CD4-
bound conformation [57,58]. In both cases high estimates of T
would reflect a decreased proportion of functional trimers on
virions. Alternatively, a high T may be required by envelopes
which have adopted a trimer conformation with a low energetic
state as described for the open conformation of lab adapted strains
[58,59]. There, the lack in energy released upon trimer
conformational rearrangements may be compensated by higher
trimer numbers roped into the entry process. Most notably, for all
three wildtype strains that yielded high estimates of T as well as the
V1V2-deleted env variants, the high T was associated with a low
infectivity (Fig. 2B, 3A and 3D). The latter is particularly
Fig. 4. Virus entry kinetics correlate with the stoichiometry of entry. (A) Entry kinetic curves for JR-FL wt and JR-FL DV1V2. Synchronized
pseudovirus infection of TZM-bl cells following spinoculation was terminated by addition of T-20 at the indicated timepoints. Infectivity reached after
120 minutes was set as 100% and all data were normalized relative to this value. Data are mean and SD from 3 independent experiments. (B) Half
maximal entry time for wt and V1V2-deleted envs was calculated from kinetic profiles shown in Fig. 4A and S7B Fig. Time (in minutes) required to
reach 50% entry into target cells is depicted. Data shown are means derived from 2 to 4 independent experiments. The p-value was calculated by a
paired t-test. (C) Correlation analysis (Pearson) of wt (black symbols) and V1V2-deleted env (red symbols) half-maximal entry time and estimated T.
doi:10.1371/journal.ppat.1004595.g004
Fig. 5. Loss of the N160 glycosylation site in gp120 steers the
stoichiometry of entry and virus infectivity. (A) Titration of CAP88
wt (black) and CAP88 K160N (red) pseudoviruses on TZM-bl reporter
cells. Data shown are mean and SD of luciferase reporter activity upon
infection measured in 2 independent experiments. Inset: Infectivity
comparison of CAP88 wt and K160N depicted as relative light units
(RLU) of luciferase reporter activity per ml of pseudovirus stock upon
infection of TZM-bl cells. The fold infectivity difference is indicated. (B)
Estimates of T for the CAP88 wt and K160N variant. Mean and range of
the individual estimates using the R508S/R511S and V513E dominant-
negative mutations are shown.
doi:10.1371/journal.ppat.1004595.g005
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intriguing as it supports the possibility that env deficiencies in entry
can be partially overcome by higher numbers of trimers engaged
during the entry process. Interesting insights also stem from the
SF162/P3N env pair: P3N was isolated from a rhesus macaque
after successive rapid transfer following initial challenge with
SHIV-SF162 [60]. While SF162 has a high estimate of T of 4 to 5,
P3N has a T of 2 and is the most infectious env in our panel
(Fig. 2B). Thus, HIV (or SIV) has the potential to evolve from a
less fit to a highly transmissible env in vivo. The exact mutations
responsible for the different phenotypes remain to be determined;
as we previously showed, the V1V2 domains of SF162 and P3N
appear to play an important role in this regard [38].
A high T was also linked with slower virus entry kinetics
(Fig. 4C) suggesting that engagement of multiple trimer-receptor
pairings requires prolonged time periods. A similar relationship
between kinetics of membrane fusion and the number of involved
fusion proteins has been previously demonstrated for SNARE
(Soluble NSF Attachment protein Receptor) complex mediated
membrane fusion [61,62] and Influenza virus membrane fusion
[16,17]. The interplay between HIV-1 entry stoichiometry and
entry kinetics our study reveals thus underscores the general
finding that the kinetics of membrane fusion processes are
governed, at least in part, by the number of participating fusion
proteins.
We rate the tight association of T with functional properties of
the envelopes, namely entry capacity and entry kinetics, as a strong
indicator of the validity of our analysis. Nevertheless, such
estimates of T can only be an approximation as certain parameters
which influence the estimates cannot be determined experimen-
tally and assumptions need to be made for the mathematical
analysis. In the literature different approaches towards modelling
of mixed trimer experiments have been described and led to
partially deviating results, highlighting the importance of validat-
ing the models and parameters used [13,14,63]. Virion trimer
numbers are commonly estimated from gp120 and p24 ELISA
data (Table 1) [23,24]. These analyses yield values for the average
envelope content of virions but do not provide information on the
frequency distribution of viruses carrying different trimer numbers
across a virion population. The latter is a factor that impacts on
the interpretation of mixed trimer experiments [14,15,64].
Fig. 6. Point mutations in JR-FL dictate virus infection efficacy and entry stoichiometry. (A) Infectivities of JR-FL wt and indicated point
mutant envs were determined by titration of virus stocks on TZM-bl reporter cells and are shown normalized to JR-FL wt. Data depict mean and SD
from 4 independent experiments. (B) Relative infectivity of mixed trimer infection experiments with the specified JR-FL variants using the R508S/
R511S and V513E dominant-negative mutations are shown. Infectivity of pseudotyped virus stocks expressing the indicated ratios of dominant-
negative mutant envs was measured on TZM-bl cells. Infectivity of virus stocks containing solely functional envelope were set as 100%. Data depict
mean and SD from 2 independent experiments. (C) Mathematical analyses of the data shown in (B) yielded estimates of T, shown here as mean and
range of the individual T estimates obtained with the R508S/R511S and V513E dominant-negative mutations. (D) Analysis of virus entry kinetics for
the four JR-FL variants were performed as shown S7A Fig.
doi:10.1371/journal.ppat.1004595.g006
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Additionally, env content estimates by ELISA do not deliver
information on env functionality, hence functional and non-
functional trimers will be accounted for [65]. A further potential
limitation stems from the nature of the mixed trimer experiments
which require that all combinations of envelopes probed lead to a
random trimer formation. Since preferential formation of homo-
trimers could strongly influence results obtained from mixed
trimer experiments, we controlled for equal expression levels of the
co-expressed env variants. In addition, previous studies from us
and others indicate that related env variants indeed form
randomly mixed trimers [13,66,67]. As outlined in our previous
work, we have incorporated in our mathematical model several
functions to capture these parameters involved in HIV entry and
carefully verified the validity of our approach in the current study
both in vitro and in silico (S1–S2 Fig., S1 Table and [15,63,68]).
Nevertheless, this does not exclude that additional parameters
beyond T contribute to the variation in entry phenotype between
individual HIV-1 strains. For instance, differences in trimer
stability or affinities for CD4 and co-receptors could significantly
impact on virus entry efficacy without direct influence on T.
Membrane fusion via the stalk-pore mechanism [11] is a multi-
step process that ultimately depends on energy provided by fusion
proteins [9,11,52,69]. Approximation of two membranes is
followed by fusion of the two proximal membrane leaflets, forming
the hemifusion stalk intermediate. Subsequent fusion of the distal
membrane leaflets creates a fusion pore, which may either expand
or close again depending on the forces exerted on the membranes.
Viral envelope glycoproteins, such as the HIV-1 env or Influenza
virus HA trimer, are metastable structures that undergo a series of
conformational changes following receptor engagement which
releases energy utilized in the fusion process [7,8]. Although the
energy required for hemifusion stalk formation could potentially
be recovered from refolding of a single envelope glycoprotein
trimer [8,55], subsequent formation of the fusion pore and pore
enlargement are thought to require higher energy levels [9,11,70].
Growing evidence suggest that only concerted action of several
trimers leads to membrane fusion and maintenance of a fusion
pore large enough to allow passage of the HIV capsid [1,9,10,20].
Our estimates that, for the majority of HIV-1 primary isolates, 2 to
3 env trimers are required to mediate infection are thus in
accordance with these studies on the mechanisms of membrane
fusion. Interestingly, our estimates of the HIV entry stoichiometry
resemble those made for Influenza A virus [16–18], postulated to
require 3 to 4 HA trimers for entry, and vesicular membrane
fusion via SNARE complexes, which generate energy during
refolding at levels comparable to viral fusion proteins [71–73]. In
high similarity to HIV and Influenza, also 1 to 3 SNARE
complexes appear to be required to induce membrane fusion
[61,62,74]. To further explore this relationship, we compared
reported values of energy required for membrane fusion and
energies released by fusion proteins (S11 Fig.). Membrane fusion
requires an energy input of 40 to 120 kbT [9,55,75,76]. Refolding
of HA trimers into the six-helix bundle conformation was
estimated to release 30 to 60 kbT [8,9,77] while SNARE complex
assembly into 4-helix bundles releases an estimated 19 to 65 kbT
[71–73,78]. Considering that 3 to 4 HAs and 1 to 3 SNARE
complexes were estimated to participate in entry, this yields total
energies of 20 to 240 kbT released during the respective
membrane fusion processes. In analogy, assuming a total energy
of 40 to 120 kbT required for membrane fusion, our estimates that
2 to 7 trimers are required for HIV entry indicate that each trimer
releases between 6 to 60 kbT during the entry process. Of note, the
calculated total energies released by both HA trimers and SNARE
complexes appear to be higher than the reported energy required
for membrane fusion. This could potentially be due to inefficient
coupling of the energy generated through protein conformational
rearrangements into membrane deformation, or divergence
between artificial membranes employed in biophysical experi-
ments to measure membrane fusion energies and naturally
occurring membranes containing proteins and having varying
lipid composition. In sum, the strong agreement in the estimated
energies across biological systems is intriguing and suggests that
the overall energy requirements of membrane fusion and
principles of energy elicitation by fusion proteins are closely
related.
Our estimates that HIV strains typically require 2 to 7 trimers
for entry are also consistent with the observations that env trimers
cluster on virions and that HIV establishes a contact zone where
several env-receptor pairings between virus and target cell are
formed, the so-called ‘‘entry claw’’ [19,28]. When defining
molecular requirements for HIV entry, it is important to consider
that envelope trimer activities may reach beyond solely providing
the energy for membrane fusion. For example, binding of HIV
trimers to their target cell receptors triggers an array of
intracellular signals, which amongst other processes is thought to
govern intracellular actin re-arrangements [79] and may be
required to support membrane fusion and pore enlargement as
previously proposed [10,11].
In summary, our estimates of the HIV entry stoichiometry are
in strong accordance with requirements found in other membrane
fusion processes. Importantly, we show that capacities of
individual HIV envelopes in mediating entry can vary substantially
which is likely due to differences between trimers in soliciting
energy required for membrane fusion. Our data strongly suggest
that viruses overcome these envelope limitations by increasing the
number of envelope-receptor pairings involved in the entry
process. Hence, the stoichiometry of HIV entry is an important
parameter steering virion infectivity and its assessment provides a
relevant contribution towards a refined understanding of HIV-1
entry and pathogenesis. Knowledge obtained from the quantita-
tive assessment of trimer-receptor interactions during HIV entry is
a prerequisite in unravelling the stoichiometry of trimer interac-
tions with target cell receptors or virus inactivation by neutralizing
antibodies and entry inhibitors and thus may aid future
approaches in HIV vaccine or entry inhibitor design.
Materials and Methods
Cells, viruses and inhibitors
293-T cells were obtained from the American Type Culture
Collection (ATCC) and TZM-bl cells [80] from the NIH AIDS
Research and Reference Reagent Program (NIH ARP). Both cell
types were cultivated in DMEM (Gibco) containing 10% heat
inactivated FCS and penicillin/streptomycin. Plasmids encoding
the envelopes of strains JR-FL, SF162, NL4-3, RHPA, AC10,
REJO, BG505 and ZM214 were obtained from the NIH ARP.
Envelope ZA110 was described previously [67]. Envelope clone
P3N [60] was a gift from Dr. Cecilia Cheng-Mayer, Aaron
Diamond AIDS Research Center, New York, USA. Envelope
clone CAP88 [81] was a gift from Dr. Lynn Morris, National
Institute for Communicable Diseases, Johannesburg, South Africa.
All envelope point mutations were generated by site-directed
mutagenesis (Agilent QuikChange II XL) according to the
manufacturer instructions. All point mutant envelopes were
sequenced by in-house Sanger sequencing to confirm presence
of the desired mutations and absence of unintended sequence
changes. V1V2-deleted envelopes were previously described [67].
The Luciferase reporter HIV pseudotyping vector pNLLuc-AM
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was previously described [67]. T-20 [82] was purchased from
Roche Pharmaceuticals.
Estimating the stoichiometry of virus entry by mixed
trimer experiments
To estimate the stoichiometry of entry we employed a
previously described approach [13]. To produce HIV-1 pseudo-
type virus stocks expressing mixed trimers with varying ratios of
functional to dominant-negative env, 293-T cells in 12 well plates
(100.000 cells per well in 1 ml complete DMEM, seeded 24 h pre-
transfection) were transfected with 1.5 mg pNLLuc-AM and 0.5 mg
env expression plasmids, using polyethyleneimine (PEI) as
transfection reagent. The ratio of functional to dominant negative
env expression plasmids was varied to yield combinations with
100, 90, 70, 50, 30, 10 and 0% of functional env. Total env
plasmid content was always at 0.5 mg. After overnight incubation
the transfection medium was replaced with 1 ml fresh complete
DMEM and virus-containing supernatants were harvested 48 h
post transfection. All mixed trimer combinations of an individual
virus strain were always generated in parallel, excluding influences
of producer cells and transfection procedure. To determine virus
infectivity, serial dilutions of virus stocks starting with 100 ml of
undiluted virus supernatant were added to TZM-bl reporter cells
in 96-well plates (10.000 cells per well) in DMEM medium
supplemented with 10 mg/ml DEAE-Dextran. TZM-bl infection
was quantified 48 h post-infection by measuring activity of the
firefly luciferase reporter. For each functional to dominant
negative env ratio series, the infectivity of the stock containing
100% functional (wt) env was taken as reference (100% infectivity)
and the relative infectivity of the stocks with increasing percentages
of dominant-negative env were calculated in relation to that
infectivity value. The resulting data of relative infectivity were
plotted over the fraction of dominant-negative env of each stock
and the data were analyzed with mathematical models [15] as
described below.
Mathematical modeling of entry stoichiometry data
Mathematical model. Previously, we described mathemat-
ical models to analyze relative infectivity data generated with
virions expressing mixed trimers [15]. Starting point of the
mathematical modeling was a basic model, in which we made the
following assumptions concerning the experimental system:
(i) During the transfection of virus producer cells, the
fraction of plasmids encoding wild-type, fwt, and mutant,
fm, envelope proteins are identical inside and outside the
cells, and the pool of produced envelope proteins inside
the transfected cell reflects these fractions as well.
(ii) Envelope proteins assemble randomly into trimers. More
precisely, the number of mutant envelope proteins in a
trimer follows a Binomial-distribution with a trial
parameter 3 and a success parameter fm.
(iii) Trimers can move freely on the viral surface, i.e. each
functional trimer can potentially engage with cellular
receptors to assist in mediating cell entry.
To verify the use of this model for our data analysis we assessed
the validity of the underlying assumptions listed above. Pseudo-
typed virions are produced by transfecting cells with different
plasmids encoding for env and the required structural and
accessory HIV proteins. This co-transfection approach and the
existence of heterotrimers in setups with plasmids encoding for
different envelope proteins show that more than one plasmid can
enter a virus producer cell. Thus, we conclude that sufficient
numbers of plasmids enter transfected cells to guarantee that the
envelope pool composition reflects the composition of plasmids
encoding for the different envelope variants, i.e. assumption (i) is
justified. Previous studies from others and us indicated that related
env variants form randomly mixed trimers [13,66,67,83], i.e.
assumption (ii) is justified. Chojnacki et al. [28]showed that trimers
on mature virions can move freely, i.e. assumption (iii) is also
justified.
The model predicts the relative infectivity of a virion stock
produced with a given fraction of mutant envelope proteins fm,
the fraction of virions with s trimers, gs 0#s#smax, and the
stoichiometry of entry, T:
RI(fm,g,T)~
Psmax
s~T
gs
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g
 
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where p= (12fm)
3 is the probability that a trimer consist of only
wild-type envelope proteins and is therefore functional. smax is the
maximal number of trimers on a virion’s surface. In the numerator
we calculate the probability that a virion with s trimers can infect a
cell, i.e. has at least T functional trimers (i.e. the expression in the
squared brackets). This probability is weighted by the probability
that a random virion has s trimers, gs. All these probabilities are
summed up for virions having at least T trimers. This expression is
then divided by the probability that a random virion expressing
only wildtype envelope proteins is infectious, because we
normalize the measured infectivities accordingly in the experi-
ments. For additional analyses of the relative infectivities we also
employed model extensions described earlier [15]. In two model
extensions we relaxed one of the assumptions (i) or (ii) as defined
above and in a third model extension we implement an
incremental increase of virus infectivity with trimer numbers.
For a more detailed derivation of the RI-predictions predictions in
the basic model and the different extensions please refer to [15].
Trimer number distributions. The trimer number distri-
bution is an important input parameter and the relative
infectivity prediction is sensitive to changes in the trimer number
distribution [15]. In our previous work, we based our estimations
of the parameter T on discretized B-distributed trimer numbers
with mean 14 and variance 49 as reported by counting trimers
on the virion surface in cryo-electron microscopy experiments
[26]. In the present study, we experimentally determined the
mean trimer numbers of the 11 different viral strains included in
our study (Table 1). However, our measurements do not allow
inferring higher moments of the distribution of the trimer
numbers, such as the variance. To overcome this problem, we
calculated the trimer number distributions using the discretized
B-distribution defined in [15] with the measured mean trimer
numbers, m (Table 1), and the variance calculated according to
v = 49/14*m [26]. The maximal trimer number, smax, was set to
100.
Analysis. To estimate T, we fitted the relative infectivity
function to experimentally obtained relative infectivity values by
assuming trimer number distributions calculated as described
above applying a non-linear regression algorithm. Because
relative infectivity data ranges from 0 to 1, the data was
transformed with the arcsin-sqrt function. To gain an accuracy
measure of our estimates, we perform a bootstrap procedure with
1000 replicates. All analyses were performed using the statistical
software package R [84]. The corresponding code is available
upon request.
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Production of pseudotype virus stocks for infectivity
assessment and entry kinetics
To produce HIV-1 pseudotype virus stocks for comparisons of
virus infectivity and determination of virus entry kinetics, 293-T
cells in T75 flasks (2.250.000 cells in 15 ml complete DMEM,
seeded 24 h pre-transfection) were transfected with env and
pNLLuc-AM plasmids (7.5 mg and 22.5 mg, respectively) using PEI
as transfection reagent. The medium was exchanged 12 h post-
transfection and virus-containing supernatants were harvested
48 h post-transfection. The supernatants were cleared by low
speed centrifugation (300 g, 3 minutes), aliquoted and stored at
280uC. Virus infectivity was quantified on TZM-bl reporter cells
as described above.
gp120 and p24 ELISA of pseudotype virus stocks
To determine gp120 and p24 content of HIV-1 pseudotype
virus preparations, 293-T cells in T25 flasks (750.000 cells in 5 ml
complete DMEM, seeded 24 h pre-transfection) were transfected
with env and pNLLuc-AM plasmids (2.5 mg and 7.5 mg, respec-
tively) using PEI as transfection reagent. The medium was
exchanged 12 h post-transfection and virus-containing superna-
tants were harvested 48 h post-transfection. The supernatants
were cleared by low speed centrifugation (300 g, 3 minutes), then
ultracentrifugated (SW28 rotor, 2 h, 28.000 rpm, 4uC), the
supernatant removed and viral pellets resuspended in 0.3 ml cold
PBS and stored at 280uC. Virion associated p24 and gp120
antigens were quantified by ELISA as previously described [67].
Briefly, virus preparations were dissolved in 1% Empigen (Fluka
Analytical, Buchs, Switzerland) and dilutions of each sample
probed for gp120 and p24. Gp120 was captured on anti-gp120
D7324 (Aalto Bioreagents, Dublin, Ireland) coated immunosor-
bent plates and detected with biotinylated CD4-IgG2 and
Streptavidin-coupled Alkaline Phosphatase (GE Healthcare,
Chalfont St Giles, UK). P24 was captured on anti-p24 D7320
(Aalto Bioreagents, Dublin, Ireland) coated plated and detected
using Alkaline Phosphatase-coupled antibody BC1071 (Aalto
Bioreagents, Dublin, Ireland). Concentrations of gp120 and p24
in the samples were calculated in relation to standard curves
obtained with gp120 and p24 proteins of known concentration. To
derive virion numbers from p24 concentrations, we assumed 2000
(for the data in main manuscript and figures) or alternatively 2400
(S3B Fig.) p24 molecules per virion [23,24,33]. Trimers per virion
were then calculated from the obtained gp120 concentration in
relation to the number of virions per sample.
Virus entry kinetics
To determine virus entry kinetics, TZM-bl cells were seeded in
96-well plates (20.000 cells per well) in complete DMEM
supplemented with 10 mg/ml DEAE-Dextran. 24 h post-seeding,
cells were first cooled at 4uC for 5 minutes, then the medium was
removed. HIV-1 pseudotype virus stocks adjusted to 50.000 RLU
in 100 ml DMEM at 4uC were added per well and plates
centrifuged for 70 minutes at 1200 g and 10uC. The low
temperature was chosen to allow virus attachment during
spinoculation but no entry. Following spinoculation the superna-
tant with unbound virus was removed and 130 ml of DMEM, pre-
warmed to 37uC, were added per well to initiate infection
(timepoint zero) and plates were incubated at 37uC. At defined
timepoints post-infection, 20 ml of T-20 (375 mg/ml in DMEM;
yielding a final assay concentration of 50 mg/ml) were added per
well to stop the viral entry process. To obtain a measure for
infectivity across different experiments, the wells with the last T-20
addition at 120 min after infection start were used as 100%
reference infectivity value and the infectivity of all other T-20
treated wells were set in relation to it. In addition, a mock-treated
well (addition of 20 ml DMEM at timepoint zero) was evaluated to
assess absolute infectivity in absence of T-20.
PBMC infection experiments
Isolation and infection of PBMCs was performed as previously
described [85]. Briefly, PBMCs were isolated from pooled buffy
coat of 3 healthy blood donors, stimulated with anti-CD3 and
PHA in presence of 100 U IL-2 for 2 days and then seeded in 96-
well plates at a density of 100.000 cells per well in 100 ml RPMI
medium supplemented with 10% FCS, antibiotics, 100 U IL-2 and
2.5 mg/ml (final assay concentration) polybrene. Serial dilutions of
mixed trimer virus stocks (100 ml per well) were added to the
PBMCs and cells were incubated at 37uC for 72 h before
determining luciferase reporter activity.
Statistical analyses
Correlation analyses according to Pearson and multiple
unpaired t-tests to derive the p-values for the comparisons of wt
and V1V2-deleted envs were performed in GraphPad Prism 6.
Supporting Information
S1 Fig Model curve fits and verification of T estimates
by bootstrap analyses. The graphs depict for each virus strain
the empirical data shown in Fig. 1B and the according curve fits
obtained with our model (‘‘basic model’’). The dominant negative
mutants are shown in black (R508S/R511S) and red (V513E)
respectively. The insets show the results of a bootstrap analysis
with 1000 replicates as a measure of accuracy of our best fit
estimate (marked with an asterisk).
(PDF)
S2 Fig Model extensions for strain CAP88. (A) to (D): To
verify if the basic model we used for data analysis is indeed the best
choice we performed three extensions of our model and show the
results here using strain CAP88 as an example; details of the model
fits for all 11 strains are listed in S1 Table. Graphs depict the
empirical data of CAP88 shown in Fig. 1B and the according
curve fits obtained with our model. The dominant negative
mutants are shown in black (R508S/R511S) and red (V513E)
respectively. (A) Fit of the basic model, as shown in S1 Fig. (B) Fit
of the imperfect transfection model which simulates incomplete
transfection of producer cells with env plasmids during production
of mixed trimer virus stocks. With this model we estimate both T
and the coefficient of variation (~v). The coefficient of variation
ranges from 0 to 1 and is a measure of how different the mixture of
envelope proteins inside the transfected cell is in comparison to the
env plasmid mixture used to transfect the cell. ~v~0 corresponds to
a perfect match (thus this is mathematically equal to the basic
model), ~v~1 correspond to cells producing only one type of
envelope protein. Note that we obtain very different estimates both
for T and the coefficient of variation despite very similar empirical
data for the two mutants. The insets show the accuracy of the
estimates determined in a bootstrap procedure with 1000
replicates (each gray point represents one bootstrap replicate);
the colored dot shows the estimated values of the best fit. (C) Fit of
the segregation model, simulating preferential segregation of the
wt and mutant envs produced in a transfected cells into
homotrimers. From this model we estimate both T and a
parameter for the magnitude of the segregation (j), ranging from
0 to 1. j=0 corresponds to perfectly randomly mixed trimers
(equal to the basic model) and j=1 corresponds to formation of wt
and mutant homotrimers only. We obtain very high estimates of T
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as well as a segregation parameter close to or equal to 1. The insets
show the results of 1000 bootstrap replicates (gray points) and the
best fit parameters (colored points). (D) Fit of the soft threshold/
incremental model, where virus infectivity scales with the trimer
number, s, according to the equation sh=(shzTh1=2). From this
model we estimate the trimer number for which 50% infectivity is
reached, T1/2, and the steepness of the infectivity increase (h). In
our analysis T1/2 cannot be bigger than 100. The insets show the
results of 1000 bootstrap replicates (gray points) and the best fit
parameters (colored points).
(PDF)
S3 Fig Extended analyses for T assuming different
mean virion trimer contents. (A) To probe the influence of
the mean virion trimer content on the estimates of T we re-
analyzed the data shown in Fig. 1B. Here, instead of the measured
individual mean trimer numbers of each strain (Table 1), identical
mean trimer numbers for all 11 strains were assumed. We chose 3
values for this comparison that covered the range of trimer
numbers measured across our panel: mean trimer numbers of 5
and 26 (representing the lowest and highest trimer contents
measured in individual experiments) and a mean trimer number of
13, the mean of trimer numbers measured across our virus panel.
Data depict the resulting estimates of T as mean and the range of
the independent estimates for both the R508S/R511S and V513E
mutations. Applying these fixed trimer numbers instead of the
individually measured values to our dataset we obtained for the
low mean trimer number of 5 the lowest estimates of T ranging
from 1 to 5 trimers. For a mean trimer number of 26, T ranged
between 3 and 17 trimers and for the mean trimer number 13, T
ranged from 1 to 10 trimers. (B) In an additional analysis we
performed a correction of the measured mean virion trimer
numbers shown in Table 1 by assuming 2400 p24 per virion
instead of 2000 p24. This results in a 20% increase in mean virion
trimer numbers. Incorporating these higher mean virion trimer
numbers in our analysis yielded the estimates of T shown here,
which are identical or slightly higher than the estimates obtained
with the original mean trimer numbers. While these comparisons
confirm that absolute numbers of T estimates can vary if there are
fluctuations in mean trimer numbers of a virus, the qualitative
differences in T amongst viruses persisted, highlighting that they
reflect qualitative entry properties of the respective virus envelopes
and less their quantitative expression.
(PDF)
S4 Fig Comparison of TZM-bl and PBMC as target cells
in mixed trimer experiments. (A) and (B): Mixed trimer virus
stocks of strains JR-FL and SF162 carrying the R508S/R511S
dominant negative mutation were assayed on TZM-bl reporter
cells and healthy donor PBMC. In both cases, the obtained PBMC
curves closely match the TZM-bl data (see also Fig. 1 D and E).
The resulting estimates of T are identical for JR-FL and deviate by
one trimer for SF162. In (C) and (D) we show bootstrap analyses
with 1000 replicates for the SF162 data, indicating that the actual
difference between the estimated T’s is small as in both cases T= 4
or 5 are the two most frequent estimates. This indicates that our
approach to estimate T is independent of target cells used and
yields results that are physiologically relevant. Data depict mean
and SD from 2 independent experiments.
(PDF)
S5 Fig Influence of V1V2-deleted virion gp120 content
on estimates of T. Virion gp120 content of V1V2-deleted envs
was experimentally determined and compared to wt virion gp120
content. Black bars depict the logarithmic fold difference between
V1V2 and wt env expression. Values are means of 2 to 3
independent experiments. The V1V2-deleted envs proved to be
expressed and incorporated into virions at similar levels as the wt
and were all in the range of 80 to 100% of the corresponding wt
envs. The actual V1V2-deleted virion mean trimer contents were
then employed in the estimation of T as shown in Fig. 3D. In
addition, to control for influences of env expression on our
estimates of T, we calculated for each wt – DV1V2 env pair the
required env content differences that theoretically would be
required to cause the observed curve shifts for V1V2-deleted
virions in the mixed trimer experiments (Fig. 3B and C), if wt and
DV1V2 strains would have identical T’s. These calculated
differences in env expression are shown for the R508S/R511S
(green bars) and V513E (red bars) mutations, respectively. While
env content certainly influences the estimation of T, we found that
only substantial env content differences (between 30 to more than
90% lower than wt for the majority of strains) would result in the
observed differences between wt and V1V2-deleted envs. Hence,
even for those viruses where expression of the V1V2 deleted env
was lower than the wt in our experiments (black bars), this loss
proofed not sufficient to induce the shifts in T we observed
(Fig. 3D). Thus these analyses confirm that the loss in entry
efficiency upon V1V2 deletion we observe is not simply caused by
lower envelope content of these virions but indeed indicates a
higher T.
(PDF)
S6 Fig Influence of increased virion trimer numbers on
estimates of T and virus population infectivity. (A–C) To
further probe the influence of trimer content on T we compared
estimates of T and infectivity of viruses on which env content was
modulated. According to our model, the amount of functional
trimers per virion, in combination with the number of trimers
required for entry (T), is a decisive parameter for virion infectivity.
(A and B) We produced mutants of JR-FL wt and JR-FL DV1V2
with a deletion of the gp41 cytoplasmic tail (CT) by replacing gp41
tyrosine 712 with a STOP codon. (A) 293-T cells were transfected
with env encoding plasmids and gp120 expression was determined
by cell surface staining with anti-gp120 MAb 2G12 and flow
cytometry. Data depict one of two representative experiments. (B)
gp120 content measurements for wt and CT deleted JR-FL wt and
JR-FL DV1V2 were performed by gp120 ELISA. Bars show
increase in gp120 content of CT truncated envs compared to full
length envelopes. Mean and SD of two independent experiments
are shown. As described [39,40] removal of the endocytosis signal
in the CT domain resulted in a higher gp120 content on the
surface of JR-FL env-expressing cells and on pseudotyped virions
(1.5 and 2-fold higher gp120 content, for JR-FL wt and JR-FL
DV1V2, respectively. (C) Infectivity of wt and CT deleted virus
stocks was determined by titration of virus supernatants on TZM-
bl cells and was recorded as activity of the luciferase reporter
(relative light unit; RLU) per ml virus stock. Data are mean and SD
from 2 independent experiments. The fold change in infectivity
upon CT deletion is indicated above the bars for both wt and
V1V2 deleted envs. CT-deleted JR-FL wt env infectivity increased
by 2.1-fold compared to full-length JR-FL wt, while infectivity of
the CT-deleted DV1V2 env was elevated 9.4-fold compared to the
CT-containing DV1V2 env. Thus, the DV1V2 env, which has a
higher T than the wt env (Fig. 3D), appears to profit more from
increased trimer numbers than the wt env, supporting the
hypothesis that the interplay between virion trimer numbers and
T is a major parameter determining virion infectivity. (D and E)
Diagrams illustrating the influence of trimer content on the
infectivity of a virus population using the example of the observed
effect of env overexpression by CT deletion on JR-FL wt (D) and
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DV1V2 envs (E). As shown in Fig. 3D, we observed a higher T for
JR-FL DV1V2 than for JR-FL wt env. Let us assume that the
distribution of trimer numbers across a population of JR-FL wt
and DV1V2 virions is similar and follows a Gaussian distribution.
Then, less virions of JR-FL DV1V2 will have the required number
of trimers (TDV1V2) than wt virions (Twt) to be infectious (for both
virion populations, only virions on the right side of the Twt or
TDV1V2 threshold are assumed to be infectious). Thus, the
infectivity of the JR-FL DV1V2 population is lower than JR-FL
wt. Upon CT deletion, the number of trimers per virion will
increase for both the JR-FL wt and DV1V2 population. For JR-FL
wt, the resulting gain in population infectivity is rather modest (2-
fold as shown in panel C), because, as indicated in (D), the
majority of JR-FL wt virions already has the required number of
trimers to be infectious and the additional proportion of virions
that shifts over the Twt threshold is rather small. However, for JR-
FL DV1V2 virions CT deletion will result in a large proportion of
virions shifting over the TDV1V2 threshold (E), thereby explaining
the larger increase in DV1V2 virion population infectivity seen
upon CT deletion (9.4-fold as shown in panel C). Thus, we
conclude that the CT deletion data support our findings of
different Ts between wt and V1V2-deleted envs and underline the
interplay between virion trimer content and T that governs virion
infectivity.
(PDF)
S7 Fig Determination of virus entry kinetics. (A) Scheme
of the time-of-inhibitor addition experiment employed to deter-
mine virus entry kinetics. In this experiment synchronized
infection of TZM-bl cells with pseudoviruses was terminated at
consecutive time points by the fusion inhibitor T-20. (B) Virus
entry kinetics for the ten pairs of wt and V1V2-deleted strains are
depicted as relative infectivity over time of T-20 addition.
Infectivity was measured following pseudovirus infection of
TZM-bl cells by recording firefly luciferase reporter activity.
Infectivity reached after 120 minutes was set as 100% and all data
were normalized relative to this value. Data are mean and SD
from 2 to 4 independent experiments. From the depicted data,
time required for each strain to reach 50% of entry as shown in
Fig. 4B of the main text are shown.
(PDF)
S8 Fig Estimation of T for the CAP88 K160N envelope
variant. Relative infectivity of mixed trimer infection experi-
ments of CAP88 wt and the K160N variant using the R508S/
R511S (A) and the V513E (B) dominant-negative mutations are
shown. Infectivity of pseudotyped virus stocks expressing the
indicated ratios of dominant-negative mutant envs was measured
on TZM-bl cells. Infectivity of virus stocks containing solely wt
envelope were set as 100%. Data depict mean and SD from 2
independent experiments. (C) Estimates of T based on the data
depicted in (A) and (B) were derived from 4 different analyses in
which we included either the experimentally derived CAP88 mean
virion trimer content (identical for both wt and K160N) or
assumed trimer contents of 5, 13 and 26 trimers per virion (see also
S3A Fig.). Data points depict mean and range of the independent
estimates for the R508S/R511S and V513E mutations.
(PDF)
S9 Fig Neutralization escape of JR-FL point mutant
envs. (A) to (C): Neutralization of virus by inhibitors was
determined by incubating virus stocks with serial dilutions of
inhibitors at 37uC for 1h. Subsequently, the virus-inhibitor mixes
were transferred to TZM-bl reporter cells and infection was
quantified 48h later by luciferase reporter read-out. Infection of
cells with mock-treated virus was set to 100% of infectivity
(0% neutralization) and % neutralization of virus incubated with
different concentrations of inhibitors was calculated in relation to
that value. Data depict mean and SD from 2 to 3 independent
experiments. (A) Neutralization of JR-FL wt and JR-FL D664N by
antibody 2F5. (B) Neutralization of JR-FL wt and JR-FL V549M
N554D by T-20. Note that the mutant is still sufficiently sensitive
to T-20 to allow assessment of entry kinetics as shown in Fig. 4D
and S7A Fig. (C) Neutralization of JR-FL wt and JR-FL N332S
P369L M373R D664N by antibodies PGT128, 2G12, b12 and
2F5.
(PDF)
S10 Fig Relation of entry stoichiometry and number of
antibodies required for neutralization. Scheme depicting
how the stoichiometry of entry influences the efficacy of HIV
virion population neutralization by antibodies. Let us assume two
virions, one with a stoichiometry of entry of 2, and one with a
stoichiometry of entry of 7 (according to Fig. 1C). Both virions
carry 13 trimers, and in both cases binding of 1 antibody per
trimer is assumed to be sufficient to block trimer functionality.
Thus, a minimum of 12 antibodies is required to neutralize the
virion with T=2, while only 7 antibodies are required to
neutralize the virion with T=7, representing a 71% difference
in antibody numbers required for neutralization. On a virus
population level, these differences in entry stoichiometry may
substantially influence the efficacy of neutralizing antibodies [56].
(PDF)
S11 Fig Summary of energies required for membrane
fusion and provided by fusion proteins. Values reported in
the literature (see main text for details) of the energies required for
biological membrane fusion or released by Influenza HA trimers
and vesicular SNARE complexes during refolding into the post-
fusion conformation are shown. Based on the reported stoichiom-
etries of Influenza virus entry and SNARE-mediated membrane
fusion we calculated the total energy contributed by these fusion
proteins during the membrane fusion process. In analogy,
assuming 40 to 120 KbT for membrane fusion and that 2 to 7
HIV-1 env trimers participate in entry, we derive that each env
trimer needs to contribute 6 to 60 KbT during refolding into the
post-fusion conformation to mediate membrane fusion. Kb is the
Boltzmann constant.
(PDF)
S1 Table Parameters and estimated T values obtained
with model extensions. We tested three extensions of our
mathematical model (referred to here as ‘‘basic model’’) to analyze
the empirical data shown in Fig. 1B. These extensions include a
model accounting for imperfect transfection, a model accounting
for envelope protein segregation and a model where we relax the
assumption of an absolute threshold for T (soft threshold model).
For the first three models we show the estimated T values, as well
as the coefficient of variation (imperfect transfection model) and a
parameter for segregation (segregation model). For the soft
threshold model we show the estimated T1/2, which is the trimer
number where 50% infectivity is reached, and the parameter h
defining the steepness of the infectivity increase. For all three
model extensions we determined the improvement of the fit
compared to the basic model with an F-test and show the
corresponding p-value as a measure of significance (p,0.05 means
significant improvement; see also S2 Fig. for details of the
alternative model fits.) These significantly better fits are not
necessarily an indication of biologically more meaningful results.
Suitability of model predictions need to be decided on by taking
the question being addressed into account and whether the
estimated parameters are in accordance with the biological system
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investigated. In our case, all models except the basic model yielded
in several cases T estimates that are far higher than what can be
expected in the context of HIV infection. In addition, the basic
model was the only one that yielded comparable T estimates for
both dominant negative mutants in the majority of the probed
strains.
(PDF)
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